Serum Biomarker Panels for the Diagnosis of Gastric Cancer

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

A Targeted Proteomics Approach Reveals a Serum Protein Signature as Diagnostic Biomarker for Resectable Gastric Cancer

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

A Novel Biomarker for Diagnosis of Bladder Cancer

Folia Pharmacologica Japonica
Pharmacology
2015English

Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis

Journal of Cancer
Oncology
2017English

Probing the O-Glycoproteome of Gastric Cancer Cell Lines for Biomarker Discovery

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2015English

Serum miR-101-3p Combined With Pepsinogen Contributes to the Early Diagnosis of Gastric Cancer

BMC Medical Genetics
Genetics
2020English

Serum Pepsinogens as a Gastric Cancer and Gastritis Biomarker in South and Southeast Asian Populations

PLoS ONE
Multidisciplinary
2020English

Serum PGLYRP‑1 Is a Highly Discriminatory Biomarker for the Diagnosis of Rheumatoid Arthritis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy